Stork Capital

Private Investment Firm Switzerland ·Founded 2019

Overview

Stork Capital is an independent, Geneva-based, regulated asset manager established by the founders of Levant Capital and Cerus Advisors to provide investment management services to its founders, private clients, and family offices. The firm specializes in private equity and venture capital investments, particularly in the healthcare and biotechnology sectors. With over 100 years of combined experience in private banking and multi-family offices, the team has held senior positions at institutions such as UBS, Credit Suisse, Merrill Lynch, and Lombard Odier. Stork Capital offers clients access to private markets, including direct opportunities and sought-after third-party funds, with a diversified allocation to private equity, private credit, real estate, and hedge funds. The firm also provides traditional wealth management solutions, including portfolio management services, merchant banking services, and wealth planning services to address family governance and wealth transfer. Stork Capital utilizes best-in-class cloud-based technology to offer on-demand account consolidation and performance reporting to facilitate diversification and risk management across custodians. The firm's portfolio includes investments in companies like Shoreline Biosciences, a biotechnology company developing cellular immunotherapies, and Structure Therapeutics, a global biopharmaceutical company developing novel oral small molecule therapeutics. Stork Capital's team has over a hundred years of combined experience, managing portfolios through five economic cycles, and is committed to delivering long-term wealth management solutions and services for private clients.

Investment Focus

  • Focus on healthcare and biotechnology sectors
  • Preference for early-stage and growth-stage companies
  • Interest in companies with innovative technologies and strong management teams
  • Willingness to engage in active portfolio management and strategic guidance
  • Alignment with Stork Capital's values and investment philosophy

Portfolio Companies

Shoreline BiosciencesStructure Therapeutics

Get the full list of 54,000+ investors

Stork Capital and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Stork Capital

What sectors does Stork Capital invest in?

Stork Capital invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in Switzerland. Stork Capital is listed as a private investment firm in the ConnectSafely investor database.

What stage does Stork Capital invest at?

Stork Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 100M.

Which regions does Stork Capital invest in?

Stork Capital invests across United States, United Kingdom, Germany, China, France and Italy.

What companies has Stork Capital invested in?

Stork Capital's portfolio includes Shoreline Biosciences and Structure Therapeutics.

Last updated · Source: ConnectSafely investor database